Last updated 2026-08-29
- Raised Seed round led by Yissum, Jan 2022
Total raised
—
Stage
—
Founded
2021
Headcount
5
HQ
Tel Aviv, Israel
Sector
Drug Delivery
Website ↗Registrar ID: 516328580 (EXONAVIS THERAPEUTICS LTD)
About
ExoNavis Therapeutics is leveraging the exosome to become a multi-drug delivery vehicle, benefiting from the unique properties of the exosomes as a targeted drug delivery platform with potentially high synergy. The company develops formulations combining nucleic acids with cationic polymers to facilitate cellular delivery and therapeutic activity targeting tumors, including those affecting the liver and pancreas, as well as multiple additional cancer types. They are also involved in the pharmaceutical development of davunetide under a licensing agreement with Ramot, Tel Aviv University's technology transfer company.
Funding history · 1 round · — total
1 event/round · — Total Funding
Jan 2022
★ Yissum★ PitchBook★ Hebrew University of Jerusalem
Headcount over time
5 employees (2026-09) · 1 point
Offices
Tel Aviv, Israel · HQ / main office
Q&A
- When was ExoNavis Therapeutics Ltd. founded?
- ExoNavis Therapeutics Ltd. was founded in 2021.
- What is ExoNavis Therapeutics Ltd.'s primary business focus?
- ExoNavis Therapeutics Ltd. is a developer of nucleic acid-based therapeutic compositions designed for cancer treatment, leveraging exosomes as a multi-drug delivery vehicle.
- Which investors participated in ExoNavis Therapeutics Ltd.'s Seed round?
- In January 2022, ExoNavis Therapeutics Ltd. raised a Seed round with participation from Yissum.
- Who is the founder of ExoNavis Therapeutics Ltd.?
- Dr. Itzik Goldwaser is the founder of ExoNavis Therapeutics Ltd., appointed in January 2021.
- What is Prof. Illana Gozes' role at ExoNavis Therapeutics Ltd.?
- Prof. Illana Gozes serves as the Vice President for Drug Development at ExoNavis Therapeutics Ltd., a position she has held since 2023.
- What types of cancer does ExoNavis Therapeutics Ltd. target with its therapies?
- ExoNavis Therapeutics Ltd. develops therapies targeting tumors, including those affecting the liver and pancreas, as well as multiple additional cancer types.
- What technology does ExoNavis Therapeutics Ltd. utilize in its drug delivery platform?
- ExoNavis Therapeutics Ltd. leverages exosome technology as a targeted drug delivery platform.
Team · 2
Dr. Itzik Goldwaser
Founder · Founder
Prof. Illana Gozes
Vice President of Drug Development
Sectors & technology
Primary sector
Drug Delivery
Technologies
Target customers
Business model
B2C
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | goldwaser.net |
|---|
Identifiers & details
| Legal name | EXONAVIS THERAPEUTICS LTD |
|---|---|
| Founded | 2021 |
| Employees (exact) | 5 |
Radar intelligence
Web history (Wayback)
| Domain | goldwaser.net |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516328580 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-01-25 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | דרך בגין 152 תל אביב - יפו |